The Asia Pacific dermal fillers market is expected to reach US$ 2,118.21 million by 2028 from US$ 949.90 million in 2021; it is estimated to grow at a CAGR of 12.1% from 2021 to 2028.
The growth of the market is attributed to the factors such as strategic activities by market players for dermal fillers and rise in adoption of injectables fillers among male population. However, the high cost of surgeries hinders the market growth.
Dermal fillers are significant, non-invasive alternative to surgical facelifts, and it improves the appearance of skin. The use of fillers in men has increased due to the rise in awareness and popularity about noninvasive procedures. A large male population is opting for various aesthetic treatments, from forehead sculpting to the chin and jawline augmentation. Since 1997, there has been a ~300% increase in cosmetic procedures performed on male patients. Neurotoxins and dermal fillers have been among the most common. Also, the market players are focusing on introducing innovative products through extensive strategic activities for dermal fillers treatment. These devices are likely to offer superior treatment outcomes compared to existing products in the market. For instance, Merz announced the launch of Belotero Lips, with products specifically designed for lip enhancement and perioral lines treatment. Thus, strategic activities and product innovations are expected to deliver an impetus to the growth of the dermal fillers market in Asia Pacific during the forecast period.
Countries in Asia Pacific are facing challenges due to increasing incidence of COVID-19. The COVID-19 pandemic has put a significant strain on the health systems of many countries in the region. Nationwide lockdowns imposed to contain the infection, along with physical distancing measures and restrictions on medical practice, have affected the training of resident doctors and other healthcare professional. At present, even in recovery phase, clinics are only seeing 50% of usual patient volume, and the number of treatments has also reduced by at least 50%. The Ministry of Health and Family Welfare of the Government of India issued guidelines that precluded OPD and elective surgeries during the pandemic. However, Japan witnessed a surge in demand for cosmetic surgeries and other procedures amid pandemics.

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
ASIA PACIFIC DERMAL FILLERS MARKET SEGMENTATION
By Product
- Biodegradable
- Non-Biodegradable
By Material
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Collagen
- Poly-L-Lactic Acid
- Polymethylmethacrylate (PMMA)
- Fat Fillers
- Other
By Application
- Facial Line Correction Treatment
- Lip Enhancement
- Face Lift
- Scar Treatment
- Others
By End User
- Dermatology Clinics
- Multispecialty Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- AbbVie Inc.
- Galderma
- Merz Pharma
- Suneva Medical
- HUADONG MEDICINE CO., LTD
- Prollenium Medical Technologies
- BIOXIS pharmaceuticals
- TEOXANE LABORATORIES
- BIOHA LABORATORIES
- BIOPLUS CO., LTD.
Asia Pacific Dermal Fillers Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 949.90 Million |
Market Size by 2028 | US$ 2,118.21 Million |
Global CAGR (2021 - 2028) | 12.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- AbbVie Inc.
- Galderma
- Merz Pharma
- Suneva Medical
- HUADONG MEDICINE CO., LTD
- Prollenium Medical Technologies
- BIOXIS pharmaceuticals
- TEOXANE LABORATORIES
- BIOHA LABORATORIES
- BIOPLUS CO., LTD.


